Skip to main content
29 June 2022
Last updated: Saturday 25 June 2022

User account anon menu

  • Login
  • Register and subscribe
Home
  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form
Menu

Breadcrumb

  1. Home
  2. Drug development robust, despite the pandemic

Drug development robust, despite the pandemic

Saturday 16 January 2021
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous

---Subscribe to MedNous to access this article---

Cancer (Oncology)
Policy & Regulation

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Colin McCracken becomes CEO of Evonetix

Saturday 25 June 2022

Valo appoints Hemanshu Shah as CBO

Saturday 25 June 2022

David Gilman to head business strategy at ADC Therapeutics

Saturday 25 June 2022

CureVac appoints new chief development officer

Saturday 25 June 2022

Steffen Thirstrup becomes CMO at the EMA

Saturday 25 June 2022
View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

  • News
  • Industry appointments
  • Events
  • Research directory
  • Subscribe

Footer

  • Privacy policy

© 2022 Evernow Publishing Ltd.

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form